Surgical treatment of pulmonary embolism
Authors: P. Němec, B. Uchytil, J. Černý, J. Ondrášek, J. Pol, P. Pokorný
Authors - sphere of activity: Centrum kardiovaskulární a transplantační chirurgie Brno, ředitel doc. MUDr. Petr Němec, CSc.
Article: Vnitř Lék 2009; 55(9): 779-782
Category: 80th Birthday - prof. MUDr. Miloš Štejfa, DrSc., FESC
Number of articles displayed: 51x
Surgical embolectomy is established method of treatment of pulmonary embolism. The aim of the study is to evaluate the experience with this procedure.
Patients and methods:
Twenty two patients, aged 22–77 years, were operated on in Centre of cardiovascular surgery and transplantation in Brno from 1999 to 2009. Nine patients suffered from massive pulmonary embolism with hemodynamic instability, 13 were stable. All the operations were performed in cardiopulmonary bypass with cross clampimg time 50.4 minutes on average. In six patients the retrograde perfusion via pulmonary veins were used. Emboli in the main trunk and/or in both pulmonary branches were found in 16 patients (72.7%). No macroscopic emboli were found in three patients, but they were flushed from the pulmonary vessels during the retrograde perfusion in two of them. Emboli or thrombi in cardiac atria or ventricles were detected in 8 patients simultaneously.
Five patients died early after operation (mortality 22.7%). The mortality was different in the group of patients with massive pulmonary embolism and cardiogenic shock (44.4%) and with submassive embolism and hemodynamic stability (7.7%).
Developments in surgical technique with retrograde perfusion offer removing of emboli not only from the pulmonary trunk and main branches, but also from the peripheral branches. It improves results and facilitates extension of indications for surgical treatment.
pulmonary embolism – surgical embolectomy
The full wording of this article is available only to registered users. Plese register and you can read this article immediately.
If you are a subscriber, log in and enter the subscriber code from your magazine cover.
If you are not a subscriber, log in for unlimited access to older editions.
Tento článek si můžete přečíst pokud si aktivujete Premium účet.
- Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic – BIBY-I study (observations lasting 3 to 12 months) | views: 78
- Risk factors for diabetic retinopathy | views: 51
- Patophysiology of diabetic retinopathy | views: 51
- What has the largest study in the history of diabetology brought us? | views: 43
- Aortic stenosis | views: 41
- Present state of diagnostic and screening of the diabetic retinopathy and diabetic macular oedema | views: 37
- Distribution of Lipoprotein‑Associated Phospholipase A2 in Czech Population and its interaction with conventional cardiovascular risk | views: 29
- Treatment of diabetic macular oedema | views: 27
- Combined therapy of arterial hypertension | views: 25
- Spondyloarthritides: Current Perspective on Diagnosis and Classification | views: 24